Cigna (CI) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
Cigna beat analysts' revenue expectations by 3.1% last quarter, reporting revenues of $69.57 billion, up 9.2% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts' revenue estimates but full-year EPS guidance in line with analysts' estimates. It lost -3,000 customers and ended up with a total of 16.35 million. Is Cigna a buy or sell going into earnings? Read our full analysis here, it's free for active Edge members This quarter, analysts are expecting Cigna's revenue to grow 6.4% year on year to $69.86 billion, slowing from the 28.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $7.88 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cigna has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (NYSE:ELV) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
- Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.MarketBeat
- Elevance Health: It Has Been Painful, But This Too Shall Pass [Seeking Alpha]Seeking Alpha
- Elevance Health (NYSE:ELV) had its price target raised by analysts at JPMorgan Chase & Co. from $394.00 to $397.00. They now have an "overweight" rating on the stock.MarketBeat
- Elevance Health (NYSE:ELV) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $390.00. They now have a "buy" rating on the stock.MarketBeat
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- 1/28/26 - Form 8-K
- ELV's page on the SEC website